Ekso Bionics Addressable Market to Grow on CMS Update - Ekso Bionics Holdings ( NASDAQ:EKSO ) , Quest Diagnostics ( NYSE:DGX )
Ekso Bionics EKSO has reached a significant milestone in terms of transforming mobility solutions, particularly for individuals with spinal cord injuries. The company recently secured initial reimbursement from the Centers for Medicare & Medicaid Services for its Ekso Indego Personal exoskeleton.
| Ticker |
Sentiment |
Impact |
|
EKSO
|
Bullish
|
58 %
|
|
TMDX
|
Somewhat Bullish
|
25 %
|
|
DGX
|
Somewhat Bullish
|
37 %
|
|
ISRG
|
Neutral
|
19 %
|
